These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

135 related items for PubMed ID: 2233757

  • 1. Complement killing of human neuroblastoma cells: a cytotoxic monoclonal antibody and its F(ab')2-cobra venom factor conjugate are equally cytotoxic.
    Juhl H, Petrella EC, Cheung NK, Bredehorst R, Vogel CW.
    Mol Immunol; 1990 Oct; 27(10):957-64. PubMed ID: 2233757
    [Abstract] [Full Text] [Related]

  • 2. Additive cytotoxicity of different monoclonal antibody-cobra venom factor conjugates for human neuroblastoma cells.
    Juhl H, Petrella EC, Cheung NK, Bredehorst R, Vogel CW.
    Immunobiology; 1997 Nov; 197(5):444-59. PubMed ID: 9413745
    [Abstract] [Full Text] [Related]

  • 3. A monoclonal antibody-cobra venom factor conjugate increases the tumor-specific uptake of a 99mTc-labeled anti-carcinoembryonic antigen antibody by a two-step approach.
    Juhl H, Sievers M, Baltzer K, Helmig F, Wolf H, Brenner W, Kalthoff H.
    Cancer Res; 1995 Dec 01; 55(23 Suppl):5749s-5755s. PubMed ID: 7493340
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Covalent conjugates of monoclonal antibody and cobra venom factor mediate specific cytotoxicity via alternative pathway of human complement activation.
    Müller B, Müller-Ruchholtz W.
    Leuk Res; 1987 Dec 01; 11(5):461-8. PubMed ID: 3573809
    [Abstract] [Full Text] [Related]

  • 8. Frequent expression of complement resistance factors CD46, CD55, and CD59 on gastrointestinal cancer cells limits the therapeutic potential of monoclonal antibody 17-1A.
    Juhl H, Helmig F, Baltzer K, Kalthoff H, Henne-Bruns D, Kremer B.
    J Surg Oncol; 1997 Mar 01; 64(3):222-30. PubMed ID: 9121154
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Antibody conjugates with cobra venom factor. Synthesis and biochemical characterization.
    Petrella EC, Wilkie SD, Smith CA, Morgan AC, Vogel CW.
    J Immunol Methods; 1987 Nov 23; 104(1-2):159-72. PubMed ID: 3500233
    [Abstract] [Full Text] [Related]

  • 11. Selective antitumor effect of thioether-linked immunotoxins composed of gelonin and monoclonal antibody to alpha-fetoprotein or its F(ab')2 fragment.
    Masuda K, Takahashi K, Hirano K, Takagishi Y.
    Tumour Biol; 1994 Nov 23; 15(3):175-83. PubMed ID: 7521059
    [Abstract] [Full Text] [Related]

  • 12. Humanized cobra venom factor: experimental therapeutics for targeted complement activation and complement depletion.
    Vogel CW, Fritzinger DC.
    Curr Pharm Des; 2007 Nov 23; 13(28):2916-26. PubMed ID: 17979736
    [Abstract] [Full Text] [Related]

  • 13. A monoclonal antibody against hinge-cleaved IgG restores effector function to proteolytically-inactivated IgGs in vitro and in vivo.
    Brezski RJ, Kinder M, Grugan KD, Soring KL, Carton J, Greenplate AR, Petley T, Capaldi D, Brosnan K, Emmell E, Watson S, Jordan RE.
    MAbs; 2014 Nov 23; 6(5):1265-73. PubMed ID: 25517311
    [Abstract] [Full Text] [Related]

  • 14. Oral (1-->3),(1-->4)-beta-D-glucan synergizes with antiganglioside GD2 monoclonal antibody 3F8 in the therapy of neuroblastoma.
    Cheung NK, Modak S.
    Clin Cancer Res; 2002 May 23; 8(5):1217-23. PubMed ID: 12006541
    [Abstract] [Full Text] [Related]

  • 15. Absence of a neutralizing antibody response to humanized cobra venom factor in mice.
    Ing M, Hew BE, Fritzinger DC, Delignat S, Lacroix-Desmazes S, Vogel CW, Rayes J.
    Mol Immunol; 2018 May 23; 97():1-7. PubMed ID: 29525557
    [Abstract] [Full Text] [Related]

  • 16. Clinically effective monoclonal antibody 3F8 mediates nonoxidative lysis of human neuroectodermal tumor cells by polymorphonuclear leukocytes.
    Kushner BH, Cheung NK.
    Cancer Res; 1991 Sep 15; 51(18):4865-70. PubMed ID: 1654202
    [Abstract] [Full Text] [Related]

  • 17. Interaction of desialated guinea pig erythrocytes with the classical and alternative pathways of guinea pig complement in vivo and in vitro.
    Brown EJ, Joiner KA, Frank MM.
    J Clin Invest; 1983 Jun 15; 71(6):1710-9. PubMed ID: 6863540
    [Abstract] [Full Text] [Related]

  • 18. Monoclonal antibody-ricin A chain conjugate selectively cytotoxic for cells bearing the common acute lymphoblastic leukemia antigen.
    Raso V, Ritz J, Basala M, Schlossman SF.
    Cancer Res; 1982 Feb 15; 42(2):457-64. PubMed ID: 6948605
    [Abstract] [Full Text] [Related]

  • 19. Carbohydrate-directed conjugation of cobra venom factor to antibody by selective derivatization of the terminal galactose residues.
    Fu Q, Gowda DC.
    Bioconjug Chem; 2001 Feb 15; 12(2):271-9. PubMed ID: 11312689
    [Abstract] [Full Text] [Related]

  • 20. Identification of functionally important amino acid sequences in cobra venom factor using human C3/Cobra venom factor hybrid proteins.
    Hew BE, Fritzinger DC, Pangburn MK, Vogel CW.
    Toxicon; 2019 Sep 15; 167():106-116. PubMed ID: 31207349
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.